相似文献
1
Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model.
Eur J Immunol. 2018 Jul;48(7):1211-1216. doi: 10.1002/eji.201847498. Epub 2018 Apr 25.
2
Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
PLoS One. 2019 Oct 24;14(10):e0217728. doi: 10.1371/journal.pone.0217728. eCollection 2019.
3
Transient Depletion of Foxp3 Regulatory T Cells Selectively Promotes Aggressive β Cell Autoimmunity in Genetically Susceptible DEREG Mice.
Front Immunol. 2021 Aug 10;12:720133. doi: 10.3389/fimmu.2021.720133. eCollection 2021.
4
Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Mol Ther. 2018 Jan 3;26(1):184-198. doi: 10.1016/j.ymthe.2017.08.014. Epub 2017 Sep 7.
5
High Thymic Output of Effector CD4 Cells May Lead to a Treg : T Effector Imbalance in the Periphery in NOD Mice.
J Immunol Res. 2019 Jun 11;2019:8785263. doi: 10.1155/2019/8785263. eCollection 2019.
6
Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
J Immunol Res. 2018 Feb 14;2018:5463879. doi: 10.1155/2018/5463879. eCollection 2018.
7
Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression.
Immunobiology. 2018 Apr-May;223(4-5):422-431. doi: 10.1016/j.imbio.2017.10.010. Epub 2017 Oct 6.
8
Thymus-Derived Regulatory T Cells Exhibit Epigenetic Modification and Phenotype Attenuation after Mating in Mice.
J Immunol. 2019 Aug 1;203(3):647-657. doi: 10.4049/jimmunol.1900084. Epub 2019 Jun 26.
9
Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes.
Immunol Res. 2018 Feb;66(1):179-186. doi: 10.1007/s12026-017-8956-5.
10
Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6335-40. doi: 10.1073/pnas.0701171104. Epub 2007 Mar 26.
引用本文的文献
1
Tissue-specific roles of regulatory T cells: mechanisms of suppression and beyond along with emerging therapeutic insights in autoimmune indications.
Front Immunol. 2025 Aug 26;16:1650451. doi: 10.3389/fimmu.2025.1650451. eCollection 2025.
2
Gluten-Free Diet Induces Small-Scale Changes Across Multiple T-Cell Subsets in NOD Mice.
Eur J Immunol. 2025 Apr;55(4):e202451559. doi: 10.1002/eji.202451559.
3
Implantation of Islets Co-Seeded with Tregs in a Novel Biomaterial Reverses Diabetes in the NOD Mouse Model.
Tissue Eng Regen Med. 2025 Jan;22(1):43-55. doi: 10.1007/s13770-024-00685-7. Epub 2024 Dec 30.
4
The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes.
JCI Insight. 2024 Dec 20;9(24):e182064. doi: 10.1172/jci.insight.182064.
5
Peripheral-derived regulatory T cells contribute to tumor-mediated immune suppression in a nonredundant manner.
Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2404916121. doi: 10.1073/pnas.2404916121. Epub 2024 Aug 29.
6
The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases.
Nat Rev Immunol. 2024 Jul;24(7):503-517. doi: 10.1038/s41577-024-00994-x. Epub 2024 Feb 19.
7
Selective ablation of thymic and peripheral Foxp3 regulatory T cell development.
Front Immunol. 2023 Dec 18;14:1298938. doi: 10.3389/fimmu.2023.1298938. eCollection 2023.
8
Tolerogenic dendritic cells in type 1 diabetes: no longer a concept.
Front Immunol. 2023 Jun 14;14:1212641. doi: 10.3389/fimmu.2023.1212641. eCollection 2023.
9
Development of Type 1 Diabetes in Mice Is Associated with a Decrease in IL-2-Producing ILC3 and FoxP3 Treg in the Small Intestine.
Molecules. 2023 Apr 11;28(8):3366. doi: 10.3390/molecules28083366.
10
Life and death of tolerogenic dendritic cells.
Trends Immunol. 2023 Feb;44(2):110-118. doi: 10.1016/j.it.2022.12.006. Epub 2023 Jan 2.
本文引用的文献
1
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial.
PLoS Med. 2016 Oct 11;13(10):e1002139. doi: 10.1371/journal.pmed.1002139. eCollection 2016 Oct.
2
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans.
Cell. 2016 May 5;165(4):842-53. doi: 10.1016/j.cell.2016.04.007. Epub 2016 Apr 28.
3
MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.
Science. 2015 Aug 28;349(6251):993-7. doi: 10.1126/science.aaa9420. Epub 2015 Aug 13.
4
Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes.
Diabetes. 2015 Nov;64(11):3891-902. doi: 10.2337/db15-0516. Epub 2015 Jul 29.
5
MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells.
Science. 2015 Aug 28;349(6251):989-93. doi: 10.1126/science.aac4263. Epub 2015 Jul 9.
6
The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes.
Cell Host Microbe. 2015 Feb 11;17(2):260-73. doi: 10.1016/j.chom.2015.01.001. Epub 2015 Feb 5.
7
tTregs, pTregs, and iTregs: similarities and differences.
Immunol Rev. 2014 May;259(1):88-102. doi: 10.1111/imr.12160.
8
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.
Nature. 2013 Dec 19;504(7480):451-5. doi: 10.1038/nature12726. Epub 2013 Nov 13.
9
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.
Nature. 2013 Dec 19;504(7480):446-50. doi: 10.1038/nature12721. Epub 2013 Nov 13.
10
Peripherally induced tregs - role in immune homeostasis and autoimmunity.
Front Immunol. 2013 Aug 7;4:232. doi: 10.3389/fimmu.2013.00232. eCollection 2013.
Zotero 插件